DRD2 and malignant colon neoplasm: Research demonstrated that dopamine inhibits angiogenesis and thereby tumour growth in animal models of colon cancer, ovarian cancer, and breast cancer via activation of dopamine receptor D2 (DRD2) [6, 7].